mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.02 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.02 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |